Heidi Floyd | CureTalks
Heidi Floyd is a sought-after influencer with over 10 years of experience in healthcare advocacy and breast cancer non-profit management. Her diverse skill set includes social media marketing, corporate philanthropy, relationship management, partnership cultivation, and program development. Heidi is a powerful communicator, international public speaker and published author. She is a passionate advocate who is effective in discussing all aspects of oncology. As a thought-leader in all things breast cancer, she highlights treatment options, quality of life and community concerns Ms. Floyd has served as the “voice of the patient” for myriad organizations including Ford, Google, the US Department of Defense, the American Cancer Society and Susan G Komen. Her experience has helped to establish and strengthen relationships with patient advocacy organizations that support patients and their families, and educate corporations on compassionate outreach to the worldwide cancer community. Her written work has been featured in Forbes, Huffington Post, CNN and The NY Times.
Related Talks
Approaches to Prevent Breast Cancer Recurrence
Breast cancer recurrence, often occurring years after initial treatment, poses a significant challenge to patients and caregivers. Dormant tumor cells, also known as…
Unraveling the Complexities of BRCA-Related Breast and Ovarian Cancers
The BRCA1 (BReast CAncer gene 1) and BRCA2 are genes that produce proteins crucial for DNA repair. Since these proteins play a pivotal…
Beyond CAR-T: Re-engineering Cells into Life-saving Therapies
Our cells have the innate ability to protect us. The idea of using cells as medicine emerged with bone marrow transplants, and then…
Cancer Therapies and Your Heart
Cancer therapies have increased the survival of cancer patients, however certain cancer treatments can damage the heart and the cardiovascular system. These side…
Drug Repurposing for COVID-19 with CORONA Registry (COvid 19 Registry of Off-label & New Agents)
The global crisis due to COVID19 and the urgent need to identify effective therapeutics prompted Dr. David Fajgenbaum from the University of Pennsylvania…